Nomenclature
CAS number: 113-18-8
1-Chloro-3-ethyl-1-penten-4-yn-3-ol; 5-chloro-3-ethylpent-1-yn-4-en-3-ol; ethyl β-chlorovinyl ethynyl carbinol; ethclorvynol; Placidyl (Abbott); Arvynol (Pfizer); Serenesil (Abbott); Roeridorm (Roerig); Normoson.
C
7H
9ClO; mol wt 144.60.
C 58.14%, H 6.27%, Cl 24.52%, O 11.06%.
Description and references
Tertiary carbinol sedative-hypnotic. Prepn:
W. M. McLamore et al., J. Org.
Chem. 20, 109 (1955); Bavley, McLamore, US 2746900 (1956 to Pfizer). Pharmacological studies: S. Y. P'an et al., J. Pharmacol. Exp. Ther. 114, 326 (1955). Pharmacodynamics: Y. C. Martin, Biochem. Pharmacol. 16, 2041 (1967).
Evaluation as hypnotic: J. W. Middleton et al., Curr. Ther. Res. 8, 391 (1966);
J. H. Pattison et al., J. Am. Geriatr.
Soc. 20, 398 (1972). Study of metabolites:
J. P. Horwitz et al., Drug Metab.
Dispos. 8, 77 (1980).
Properties
Liquid, pungent aromatic odor. Slowly darkens
on exposure to light and air. d425 1.065-1.070 (also
reported as d420 1.070). bp760 173-174° (also reported as bp760 181°); bp0.1 28.5-30°. nD25 1.4675-1.4800. Immiscible with water; miscible with most organic solvents.
LD50 in mice (mg/kg): 290 orally; 240 s.c. (P'an).Note
This is a controlled substance (depressant):
21 CFR, 1308.14.Therapeutic Category
Sedative, hypnotic.
Keywords
Sedative/Hypnotic; Alcohols